Abstract
Drugs obtained from human blood, such as coagulation factors and antibody preparations, are manufactured from large pools of plasma; this leads to contamination with viruses from a very wide range of groups.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
LoGrippo GA, Hartman FW. Chemical and combined methods for plasma sterilization. Bibl. Haematologica 1958; 7: 255–30.
Murray R, Oliphant JW, Tripp JT et al. Effect of ultraviolet radiation on the infectivity of icterogenic plasma. JAMA 1955; 157: 8–14.
Barker LF, Murray R. Acquisition of hepatitis-associated antigen. Clinical features in young adults. JAMA 1971; 216: 1970–6.
Pruggmayer D, Stephan W. Gas chromatographic trace analysis of 3-propriolactone in sterilized serum proteins. Vox Sang 1976; 31: 191–8.
Lissner RW, Pincus JH, Mortelmans K, Tanaka W. On the mutagenicity of 3-propiolactone-treated therapeutic blood products. Lecture and Symposium Abstracts of the Hematology/Transfusion Congress Montreal 1980, No. 478.
Kornhuber B. Studie zur Hepatitissicherheit der Serumkonserve Biseko. Biotest-Mitteilungen 1974; 35: 44–5.
Kohler-Vajta K, Klose HJ, Frosner G. Klinische Priifung auf Hepatitis-sicherheit eines “hepatitis-sicheren” Prothrombinkomplexes Prothrombinkomplexes in padiatrischem Krankengut. In: JR Kalden u. UD Koenig (Hrsg.) Blutkomponenten und Plasmaersatzmittel. Springer-Verlag Berlin, Heidelberg, New York 1982: 113–6.
Prince AM, Stephan W, Brotman B. 3-propiolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivatives. Rev. Infect, Dis. 1983; 5: 92–107.
Heinrich D, Kotitschke R, Berthold H. Clinical evaluation of the hepatitis safety of a 3-propiolactone/ultraviolet treated factor IX concentrate (PPSB). Thromb. Res. 1982; 28: 75–83.
Stephan W, Berthold H. Untersuchungen zur Hepatitissicherheit von sterilisierten Gerinnungsfaktoren aus Humanblut — Eine Schimpansen- studie. In: Kl. Schimpf (Hrsg.) Fibrinogen, Fibrin und Fibrinkleber. Nebenwirkungen der Therapie mit Gerinnungsfaktorenkonzentraten. F.K. Schattauer Verlag Stuttgart, New York 1980: 321–5.
Prince AM, Stephan W, Brotman B. Inactivation of non-A, non-B virus infectivity by a 3~propiolactone/ultraviolet irradiation treatment and Aerosil adsorption procedure used for preparation of a stabilized human serum. Vox Sang 1984; 46: 80–5.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Stephan, W., Dichtelmüller, H., Kotitschke, R., Prince, A.M., Friis, R.R., Bauer, H. (1985). Inactivation of Hepatitis Viruses (B, Non-A/Non-B) and Retroviruses in Pooled Human Plasma by Means of β-Propiolactone-and UV-Treatment. In: Smit Sibinga, C.T., Das, P.C., Seidl, S. (eds) Plasma Fractionation and Blood Transfusion. Developments in Hematology and Immunology, vol 13. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2631-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2631-1_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9644-7
Online ISBN: 978-1-4613-2631-1
eBook Packages: Springer Book Archive